Mylan Gets Some Parts Of Investors' EpiPen Suit Trimmed
After trimming some claims and statements, a New York federal judge said Friday that he would not dismiss all of the new claims in an amended investor suit against Mylan NV...To view the full article, register now.
Already a subscriber? Click here to view full article